Your browser doesn't support javascript.
loading
Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer.
Kobayashi-Kato, Mayumi; Fujii, Erisa; Asami, Yuka; Ahiko, Yuka; Hiranuma, Kengo; Terao, Yasuhisa; Matsumoto, Koji; Ishikawa, Mitsuya; Kohno, Takashi; Kato, Tomoyasu; Shiraishi, Kouya; Yoshida, Hiroshi.
Affiliation
  • Kobayashi-Kato M; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Fujii E; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Asami Y; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo 142-8555, Japan.
  • Ahiko Y; Division of Frontier Surgery, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Hiranuma K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.
  • Terao Y; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.
  • Matsumoto K; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo 142-8555, Japan.
  • Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Kato T; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. Electronic address: kshirais@ncc.go.jp.
  • Yoshida H; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo 104-0045, Japan. Electronic address: hiroyosh@ncc.go.jp.
Gynecol Oncol ; 178: 36-43, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37748269
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Endometrial Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Endometrial Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States